$260.67−0.48%Close 17 Nov 2026 · Market value $25.22B
In its results release of 4 Nov 2026 (Q2 FY2027), STERIS plc gave 1 forecast in figures, among them EPS (adjusted) of $11.35 to $11.55 for FY2027. Over the last two years, results landed above the company's own last range 2 of 4 times, within it 2 and below it 0.
Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.
Latest guidance given with Q2 FY2027 results, 4 Nov 2026
| Measure | Period | Guidance | As stated |
|---|
| EPS · Adjusted | FY2027 | $11.35 to $11.55 | Adjusted earnings per diluted share are now anticipated to be in the range of $11.35 to $11.55, an increase from prior expectations of $11.10 to $11.30 |
|---|
Source: the company's earnings release.
Guidance against results above 2 · within 2 · below 0
The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.
| Measure | Period | Last guidance | Revisions | Delivered | Result |
|---|
| Organic revenue growth | FY2027 | +6% to +7% | Given once | — | To come |
|---|
| EPS · Adjusted | FY2027 | $11.35 to $11.55 | Raised once | — | To come |
|---|
| Free cash flow | FY2027 | About $800M | Given once | — | To come |
|---|
| Capital expenditures | FY2027 | About $450M | Raised once | — | To come |
|---|
| Capital expenditures | FY2026 | About $375M | Unchanged | $369M | Within the range |
|---|
| Tax rate | FY2026 | About 24% | Unchanged | 25.04% | Above the range |
|---|
| Capital expenditures | FY2025 | About $360M | Unchanged | $370M | Above the range |
|---|
| Tax rate | FY2025 | About 23% | Unchanged | 23.2% | Within the range |
|---|
STE in the terminal
Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.